A dealer may elect to use a process to reduce Vibrio vulnificus levels in molluscan shellfish.

1. (1) The dealer shall:

   1. (A) have an HACCP plan acceptable to the department for the process which includes:

      1. (i) an end point criteria for the process as non-detectable (less than 3 MPN/gram) using the FDA approved EIA procedure of Tamplin, et al, as detailed in Chapter 9 of the FDA Bacteriological Analytical Manual, 7th edition, 1992; and
      2. (ii) a sampling program to demonstrate that the end point criteria is met.
   2. (B) package and label all molluscan shellfish in accordance with the requirements in this chapter of this title (relating to Molluscan Shellfish) including labeling all molluscan shellfish which has been subjected to the process but which is not frozen in accordance with the molluscan shell stock labeling requirements in §241.62 of this title (relating to Dealer Molluscan Shell Stock Identification); and
   3. (C) keep records in accordance with the requirements in this chapter of this title (relating to Molluscan Shellfish).
2. (2) A dealer who meets the requirements of this section may label product which has been subjected to the reduction process as "Processed to reduce Vibrio vulnificus to non-detectable levels."

Source Note:The provisions of this §241.64 adopted to be effective May 10, 1998, 23 TexReg 4273.